Operating Income: The income after operating expenses.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) had Operating Income of $4.01B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$8.43B |
|
$2.91B |
|
$2.44B |
|
$5.99B |
|
$4.42B |
|
|
Operating Income |
$4.01B |
$-6.87M |
|
$4.01B |
|
$4.01B |
|
$2.91B |
|
$2.91B |
|
$2.91B |
|
$2.91B |
|
$4.01B |
|
$4.23B |
|
3.29B |
|
3.29B |
|
$0.88 |
|
$0.88 |
|
| Balance Sheet Financials | |
$11.66B |
|
$3.06B |
|
$4.88B |
|
$16.54B |
|
$2.75B |
|
-- |
|
$212.95M |
|
$2.97B |
|
$13.57B |
|
$13.21B |
|
$13.57B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$2.59B |
|
$-1.35B |
|
$-2.06B |
|
$3.62B |
|
$2.86B |
|
$-761.12M |
|
-- |
|
$-2.01B |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
71.09% |
|
47.60% |
|
47.60% |
|
50.19% |
|
47.52% |
|
34.50% |
|
$2.13B |
|
-- |
|
-- |
|
-- |
|
0.51 |
|
1.31 |
|
2.84 |
|
128.57 |
|
21.42% |
|
22.02% |
|
17.58% |
|
21.43% |
|
$4.12 |
|
$0.65 |
|
$0.79 |
|